Diagnostic Utility of Molecular Investigation in Extraskeletal Myxoid Chondrosarcoma-Reference-Cited by-同舟云学术

Diagnostic Utility of Molecular Investigation in Extraskeletal Myxoid Chondrosarcoma

Published:2014-05 Issue:3 Volume:16 Page:314-323
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Benini Stefania,Cocchi Stefania,Gamberi Gabriella,Magagnoli Giovanna,Vogel Daniela,Ghinelli Cristina,Righi Alberto,Picci Piero,Alberghini Marco,Gambarotti Marco

Funder

Italian Ministry of Health

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference34 articles.

1. Extrascheletal myxoid chondrosarcoma;Lucas,2013

2. Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics;Hisaoka;Pathol Int,2005

3. Extraskeletal myxoid chondrosarcoma: a reappraisal of its morphologic spectrum and prognostic factors based on 117 cases;Meis-Kindblom;Am J Surg Pathol,1999

4. Extraskeletal myxoid chondrosarcoma. An analysis of 34 cases;Enzinger;Hum Pathol,1972

5. Extraskeletal myxoid chondrosarcoma: a Multi-Institutional Study of 42 Cases in Japan;Kawaguchi;Cancer,2003

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extraskeletal myxoid chondrosarcoma: A study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphological variants associated with non-EWSR1::NR4A3 fusions;Human Pathology;2023-04

2. Keratin‐positive fibrotic extraskeletal myxoid chondrosarcoma: a close mimic of myoepithelial tumour;Histopathology;2023-02-27

3. The Efficacy of Molecular Analysis in the Diagnosis of Bone and Soft Tissue Sarcoma: A 15-Year Mono-Institutional Study;International Journal of Molecular Sciences;2022-12-30

4. Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome — an immunohistochemical and molecular analysis of 31 cases;Virchows Archiv;2022-11-14

5. Identification of Novel PGR-NR4A3 Fusion in Extraskeletal Myxoid Chondrosarcoma and Resultant Patient Benefit From Tamoxifen Therapy;JCO Precision Oncology;2022-08